Memorial seventh-floor LifeCare patient injection incident

The Memorial seventh-floor LifeCare patient injection incident refers to allegations that patients awaiting evacuation from Memorial Medical Center on September 1, 2005, were given lethal doses of medication. LifeCare employees later described conversations and events that placed Anna Pou and two unnamed Memorial nurses in the unit, while physical evidence confirmed that drugs were present in some patients’ remains. The accounts did not settle every question: witnesses differed in what they had heard directly, and toxicology could not alone establish whether medication caused a particular death or what anyone intended. The episode became a test of how a distressing, increasingly corroborated allegation could be investigated without treating allegation, drug exposure, causation, and criminal intent as interchangeable conclusions.

The crisis and the seventh-floor conversation

On the morning of Thursday, September 1, the hospital remained in an emergency evacuation. LifeCare patients had been placed low in the evacuation order, and staff had spent the previous night trying to keep them alive and stable. In a later interview, assistant administrator Diane Robichaux recalled that she and colleagues had spoken with Susan Mulderick, who said the plan was not to leave living patients behind. When Robichaux returned to LifeCare’s seventh floor, she encountered Pou. Robichaux recalled Pou saying that the patients would not survive, but qualified her memory of the precise words. Pou asked whether LifeCare staff would remain on the unit; Robichaux said she did not want them there.

The discussion turned to Emmett Everett, a sixty-one-year-old patient who was conscious and aware but weighed about 380 pounds and was paralyzed. Robichaux recalled that staff considered whether he could be moved down the stairs and through an opening to reach a helicopter. When evacuation seemed physically doubtful, Pou asked whether a staff member Everett trusted could sedate him. Robichaux identified a strong nurse named Andre, then refused to let him take part. Before the LifeCare staff left the floor, Robichaux recalled Pou telling her not to feel responsible and assuring her, in substance, that Pou would take responsibility and that LifeCare employees should not fear for their licenses.

Robichaux’s account distinguished what she said she heard from what she had learned from a colleague. She did not recall Pou directly telling her that lethal doses would be administered. That phrase, she told investigators, had been related to her by Therese Mendez, LifeCare’s nurse executive. The distinction mattered: her account supported the report of a troubling plan, but did not establish that she personally heard Pou state it.

Mendez and Johnson describe the order

Mendez, who returned to the seventh floor after working overnight elsewhere in the hospital, said she saw severely ill patients and believed they might not survive. In her account, Pou told her that the patients would probably die, then said a decision had been made to administer lethal doses. Mendez remembered asking which drugs were involved. She recalled morphine and Ativan, but could not reliably name the rest. She also said she asked whether the plan applied only to LifeCare patients. According to Mendez, Pou said it did not, and told LifeCare staff to gather their belongings and leave because other hospital employees were coming to assist.

Mendez said she gathered her colleagues in tears. She had watched nurses and aides work to sustain the patients through the night, and believed they should not have to witness what she thought was about to happen. Her account also explained why she did not challenge the instruction: she believed Pou was acting under orders from a higher authority and thought the hospital was under martial law, with the military making decisions. The investigators recorded this as Mendez’s understanding, not as proof that such orders existed.

Kristy Johnson recalled hearing Mulderick say that the plan was not to leave living patients behind. She also remembered Mendez calling her back to LifeCare and telling her that patients would receive a lethal dose. Johnson said she was shocked, and understood the situation through an earlier report that a physician had said they were under martial law. Her recollection of the Everett discussion was less certain: when Virginia Rider asked whether she had heard Pou request that he be sedated, Johnson could not tell whether she had heard it herself or had learned the detail from colleagues while waiting to evacuate. She did recall Pou saying that the patients would be in the care of hospital staff. Investigators asked Johnson about twenty-three deceased LifeCare patients; she identified when or where she had last seen them alive.

Supplies, rooms, and conflicting degrees of certainty

LifeCare pharmacist Steven Harris gave investigators another account. He said he heard Mulderick discuss the patients’ poor prospects and then spoke with Pou on the seventh floor alongside Robichaux. Harris recalled Pou saying that lethal doses would be given. He also recalled Robichaux telling Pou that Everett was conscious, and Pou asking for someone to talk with or sedate him; Harris said a nurse refused. Unlike Robichaux’s qualified recollection, Harris said he directly heard the words about lethal doses.

Harris described practical details that investigators could test against records and physical evidence. When he asked what medications Pou planned to use, he said she showed him a large package of morphine vials and several loose vials. He provided syringes and sterile-saline vials, used to flush medication through an intravenous catheter. Harris said Pou and two unnamed nurses prepared syringes, later entered rooms where patients remained, and then headed toward a staircase carrying one or more translucent garbage bags. He did not know what the bags contained. He said Johnson later told him that Pou had asked staff to check on patients and pull sheets over those who had died. Harris was not present to verify what occurred inside the rooms, and his account of the bags did not identify their contents.

The witnesses’ accounts converged on a serious allegation, but were not identical in their evidentiary reach. Mendez and Harris said Pou explicitly described lethal doses; Robichaux attributed that wording to Mendez rather than to her own conversation with Pou; and Johnson was uncertain about whether she personally heard the request to sedate Everett. Investigators noted that the LifeCare accounts corroborated one another and that all nine patients identified by staff as the surviving patients on the seventh floor died. They still needed to establish what happened, who participated, and whether physical evidence supported the allegations. Their search priorities included medical and pharmacy records, evacuation plans, employee information, computer drives, and medical waste that might contain discarded vials or syringes.

Toxicology and the limits of proof

After the deaths, the bodies remained unrefrigerated in extreme heat for more than a week. Orleans Parish coroner Frank Minyard initially told Rider that examining them might be of little use, since decomposition made blood sampling impossible. A volunteer pathologist pointed out that drugs might remain detectable in liver, brain, muscle, or fluid collected in the abdomen. At the attorney general’s request, Minyard agreed to seek tissue examinations. On September 22, investigators took samples from eighteen Memorial Medical Center bodies to National Medical Services, Inc., a forensic toxicology laboratory in Willow Grove, Pennsylvania.

The laboratory reported that nine of the eighteen cases were positive for morphine and that roughly five or six more were positive for midazolam. The names associated with positive findings included patients on the investigators’ list of suspected deaths: Harold Dupas, Hollis Alford, Wilda McManus, Elaine Nelson, Emmett Everett, Alice Hutzler, Rose Savoie, Ireatha Watson, and George Huard. The apparent correspondence was striking, and the laboratory had not been told which names were on the list. But detection was not, by itself, a complete account of how or when a drug was given, whether it caused death, or whether an administrator intended to kill.

Later expert review made that distinction explicit. Of forty-one Memorial and LifeCare bodies tested, twenty-three contained morphine, midazolam, or both. The reviewers cautioned that postmortem tissue results were harder to interpret than blood tests from living patients, particularly after prolonged exposure to heat. They examined each patient’s clinical history alongside the laboratory findings and considered whether drugs might have accumulated through repeated dosing or impaired processing associated with illness. In Alice Hutzler’s case, both drugs were found in liver, brain, and muscle, although her medical chart showed neither drug had been prescribed; the chart recorded her as resting comfortably the previous afternoon and contained no documented pain or distress that night.

The experts did not agree on what the findings could establish. Steven Karch argued that drug levels in bodies exposed to high temperatures could not reliably determine the levels before death, and advised that the medical causes remain undetermined. Michael Baden countered that, whatever the uncertainty about dosage, the drugs were present and there was no competing cause of death in the cases he discussed. Cyril Wecht considered some measured levels extraordinarily high and reported a small, unpublished experiment in which hot, humid conditions did not significantly alter drug levels in overdose samples. The experiment was limited and not independently vetted. The evidence therefore accumulated in layers: witness accounts described a plan and preparations; laboratory results established drug exposure in some bodies; clinical records and expert disagreement complicated conclusions about timing, causation, and intent.